HINT1 neuropathy: Expanding the genotype and phenotype spectrum

Inherited peripheral neuropathy (IPN) is a heterogeneous group of disorders due to pathogenic variation in more than 100 genes. In 2012, the first cases of IPN associated with HINT1 pathogenic variations were described in 33 families sharing the same phenotype characterized by an axonal neuropathy with neuromyotonia and autosomal recessive inheritance (NMAN: OMIM #137200). Histidine Triad Nucleotide Binding Protein 1 regulates transcription, cell‐cycle control, and is possibly involved in neuropsychiatric pathophysiology. Herein, we report seven French patients with NMAN identified by Next Generation Sequencing. We conducted a literature review and compared phenotypic and genotypic features with our cohort. We identified a new HINT1 pathogenic variation involved in NMAN: c.310G>C p.(Gly104Arg). This cohort is comparable with literature data regarding age of onset (7,4yo), neuronal involvement (sensorimotor 3/7 and motor pure 4/7), and skeletal abnormalities (scoliosis 3/7, feet anomalies 6/7). We expand the phenotypic spectrum of HINT1‐related neuropathy by describing neurodevelopmental or psychiatric features in six out of seven individuals such as generalized anxiety disorder (GAD), obsessive–compulsive disorder (OCD), mood disorder and attention deficit hyperactivity disorder (ADHD). However, only 3/128 previously described patients had neuropsychiatric symptomatology or neurodevelopmental disorder. These features could be part of HINT1‐related disease, and we should further study the clinical phenotype of the patients.

[1]  Xiaoliu Shi,et al.  Myasthenia gravis coexisting with HINT1-related motor axonal neuropathy without neuromyotonia: a case report , 2022, BMC Neurology.

[2]  M. Cossée,et al.  A National French Consensus on Gene List for the Diagnosis of Charcot–Marie–Tooth Disease and Related Disorders Using Next-Generation Sequencing , 2022, Genes.

[3]  Sha Li,et al.  HINT1 deficiency in aged mice reduces anxiety-like and depression-like behaviours and enhances cognitive performances , 2022, Experimental Gerontology.

[4]  A. Mazzeo,et al.  Rare among Rare: Phenotypes of Uncommon CMT Genotypes , 2021, Brain sciences.

[5]  Y. Onetti,et al.  The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain , 2021, Biomolecules.

[6]  G. Koutsis,et al.  HINT1-related neuropathy in Greek patients with Charcot-Marie-Tooth disease. , 2021, Journal of the peripheral nervous system : JPNS.

[7]  A. Jordanova,et al.  HINT1 founder mutation causing axonal neuropathy with neuromyotonia in South America: A case report , 2021, Molecular genetics & genomic medicine.

[8]  A. Jordanova,et al.  HINT1 neuropathy in Norway: clinical, genetic and functional profiling , 2021, Orphanet Journal of Rare Diseases.

[9]  M. Rodríguez-Muñoz,et al.  Human HINT1 Mutant Proteins that Cause Axonal Motor Neuropathy Exhibit Anomalous Interactions with Partner Proteins , 2020, Molecular Neurobiology.

[10]  Liu Yang,et al.  Does genetic mouse model of constitutive Hint1 deficiency exhibit schizophrenia-like behaviors? , 2020, Schizophrenia Research.

[11]  E. Bertini,et al.  Response to “Autosomal recessive axonal neuropathy caused by HINT1 mutation: New association of a psychiatric disorder to the neurological phenotype” , 2020, Neuromuscular Disorders.

[12]  E. Dadali,et al.  HINT1 gene pathogenic variants: the most common cause of recessive hereditary motor and sensory neuropathies in Russian patients , 2019, Molecular Biology Reports.

[13]  Wanjin Chen,et al.  Whole exome sequencing reveals a broader variant spectrum of Charcot-Marie-Tooth disease type 2 , 2019, neurogenetics.

[14]  Yunqiang Liu,et al.  [Analysis of HINT1 gene variant in a case with neuromyotonia and axonal neuropathy]. , 2019, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[15]  M. Rodríguez-Muñoz,et al.  The Axonal Motor Neuropathy-Related HINT1 Protein Is a Zinc- and Calmodulin-Regulated Cysteine SUMO Protease , 2019, Antioxidants & redox signaling.

[16]  C. Spagnoli,et al.  Autosomal recessive axonal neuropathy caused by HINT1 mutation: New association of a psychiatric disorder to the neurologic phenotype , 2019, Neuromuscular Disorders.

[17]  V. Zhang,et al.  Novel mutations in HINT1 gene cause the autosomal recessive axonal neuropathy with neuromyotonia. , 2019, European journal of medical genetics.

[18]  Wei Zhang,et al.  Novel mutations in HINT1 gene cause autosomal recessive axonal neuropathy with neuromyotonia in two cases of sensorimotor neuropathy and one case of motor neuropathy , 2018, Neuromuscular Disorders.

[19]  E. Chroni,et al.  A first case report of HINT1-related axonal neuropathy with neuromyotonia in a Greek family , 2016, Clinical Neurology and Neurosurgery.

[20]  C. Fauth,et al.  A Novel Variant in the HINT1 Gene in a Girl with Autosomal Recessive Axonal Neuropathy with Neuromyotonia: Thorough Neurological Examination Gives the Clue , 2016, Neuropediatrics.

[21]  M. Shy,et al.  A case of neuromyotonia and axonal motor neuropathy: A report of a HINT1 mutation in the United States , 2015, Muscle & nerve.

[22]  Peng Liu,et al.  HINT1 is involved in the behavioral abnormalities induced by social isolation rearing , 2015, Neuroscience Letters.

[23]  D. Pareyson,et al.  Novel loss‐of‐function mutation of the HINT1 gene in a patient with distal motor axonal neuropathy without neuromyotonia , 2015, Muscle & nerve.

[24]  M. Reilly,et al.  Absence of HINT1 mutations in a UK and Spanish cohort of patients with inherited neuropathies , 2015, Journal of Neurology.

[25]  J. Ferralli,et al.  The Intracellular Domain of Teneurin-1 Induces the Activity of Microphthalmia-associated Transcription Factor (MITF) by Binding to Transcriptional Repressor HINT1 , 2015, The Journal of Biological Chemistry.

[26]  D. Lambrechts,et al.  Exome sequencing reveals HINT1 mutations as a cause of distal hereditary motor neuropathy , 2013, European Journal of Human Genetics.

[27]  P. Seeman,et al.  Mutations in HINT1 are one of the most frequent causes of hereditary neuropathy among Czech patients and neuromyotonia is rather an underdiagnosed symptom , 2014, neurogenetics.

[28]  P. D. Rijk,et al.  Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia , 2012, Nature Genetics.

[29]  K. Kendler,et al.  Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence , 2011, The Pharmacogenomics Journal.

[30]  F. Holsboer,et al.  Increased anxiety-related behaviour in Hint1 knockout mice , 2011, Behavioural Brain Research.

[31]  V. Pantesco,et al.  Distinct Transcriptome Expression of the Temporal Cortex of the Primate Microcebus murinus during Brain Aging versus Alzheimer's Disease-Like Pathology , 2010, PloS one.

[32]  S. Iacobelli,et al.  Biological indicators of prognosis in Ewing's sarcoma: An emerging role for lectin galactoside‐binding soluble 3 binding protein (LGALS3BP) , 2010, International journal of cancer.

[33]  K. Kendler,et al.  Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia? , 2008, Schizophrenia Research.

[34]  O. Huber,et al.  The Histidine Triad Protein Hint1 Triggers Apoptosis Independent of Its Enzymatic Activity* , 2006, Journal of Biological Chemistry.

[35]  M. Baron,et al.  Genetics of schizophrenia and the new millennium: progress and pitfalls. , 2001, American journal of human genetics.